The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 0/1 biomarker and pharmacodynamic study of roflumilast and prednisone in patients with B-cell hematologic malignancies.
 
Alex V Mejia
No Relationships to Disclose
 
Ricardo Aguiar
No Relationships to Disclose
 
Anand B. Karnad
No Relationships to Disclose
 
John G. Kuhn
Consulting or Advisory Role - Azaya Therapeutics; TG Therapeutics
Speakers' Bureau - Amgen
 
Ivan Alexander Reveles
No Relationships to Disclose
 
Stephanie Hodges
No Relationships to Disclose
 
Suhasini Avvaru
No Relationships to Disclose
 
Sumit Madan
No Relationships to Disclose
 
Kevin Kelly
Honoraria - Celgene; Novartis
Consulting or Advisory Role - Novartis
Speakers' Bureau - Novartis
 
Steven D. Weitman
Leadership - Tolero Pharmaceuticals
Stock and Other Ownership Interests - Azaya Therapeutics; miRNA Therapeutics; Tolero Pharmaceuticals
Consulting or Advisory Role - Amgen; Azaya Therapeutics; Millennium; miRNA Therapeutics; Sanofi; Sunesis Pharmaceuticals; Tolero Pharmaceuticals
Travel, Accommodations, Expenses - Acetylon Pharmaceuticals; Sunesis Pharmaceuticals; Tolero Pharmaceuticals